Malamati Kourti
Assistant Professor, Pharmacy
22713278
School of Sciences
Department of Life Sciences
Qualification | Year | Awarding Institution | Department | Thesis title (Optional Entry) |
Doctor of Philosophy | 2019 | Cardiff University | Medicine, Pharmacy & Pharmaceutical Sciences | Combining carbon monoxide-releasing molecules with anti-VEGF therapy for triple-negative breast cancer therapy |
Master of Sciences | 2015 | Aristotle University of Thessaloniki | Pharmacy | Design, synthesis and biological evaluation of new anti-dyslipidemic morpholines with pleiotropic activity |
Bachelor of Sciences | 2013 | Aristotle University of Thessaloniki | Pharmacy | Structurally improved antioxidant Trolox derivatives with pleiotropic activity |
Period of employment | Employer | Location | Position | |
From | To | |||
Sept 2019 | European University Cyprus | Nicosia, Cyprus | Lecturer |
Ref. Number | Year | Title | Other authors | Journal and Publisher / Conference | Vol. | Pages |
To be determined | 2019 | Structural modifications on CORM-3 lead to enhanced antiangiogenic properties against triple-negative breast cancer (accepted for publication) | Cai J, Jiang W, Westwell A. | Medicinal Chemistry | - | - |
doi: 10.18632/oncotarget.26638 | 2019 | Repurposing old carbon monoxide-releasing molecules towards the anti-angiogenic therapy of triple-negative breast cancer | Westwell A, Jiang W, Cai J. | Oncotarget | 10 (10) | 1132-1148 |
doi: 10.1155/2017/9326454 | 2017 | Aspects of carbon monoxide (CO) in form of CO-releasing molecules (CORMs) used in cancer treatment: more light on the way | Jiang W, Cai J. | Oxidative Medicine and Cellular Longevity | - | - |
doi: 10.1111/cbdd.12936 | 2017 | Virtual screening, SAR and discovery of 5-(indole-3-yl)-2-[(2-nitrophenyl)amino] [1,3,4]-oxadiazole as a novel Bcl-2 inhibitor | Ziedan NI, Hamdy R, Cavaliere A, Prencipe F, Brancale A, Jones AT, Westwell AD. | Chemical Biology & Drug Design | 90 (1) | 147-155 |
doi: 10.1016/j.bmcl.2015.12.063 | 2016 | Amides of non-steroidal anti-inflammatory drugs with thiomorpholine can yield hypolipidemic agents with improved anti-inflammatory activity | Theodosis-Nobelos P, Gavalas A, Rekka EA. | Bioorganic Medicinal Chemistry Letters | 26 (3) | 910-913 |
doi: 10.1016/j.bmcl.2015.10.036 | 2016 | Esters of some nonsteroidal anti-inflammatory drugs with cinnamyl alcohol are potent lipoxygenase inhibitors with enhanced anti-inflammatory activity | Theodosis-Nobelos P, Tziona P, Kourounakis PN, Rekka EA. | Bioorganic Medicinal Chemistry Letters | 25 (22) | 5028-5031 |
- | 2014 | Design of multi-targeting morpholines against hyperlipidaemias | Vellios A, Rekka E, Kourounakis P. | Chemistry -Medicinal Chemistry (EFMC XXIIIrd International Symposium on Medicinal Chemistry) | Poster P020 | 250 |
- | 2014 | New potent anti-inflammatory agents through combination of non-steroidal anti-inflammatory drugs with bioactive alcohols | Tziona P, Theodosis-Nobelos P, Gavalas A, Rekka EA, Kourounakis PN. | 6th International Conference on Oxidative Stress in Skin Medicine and Biology | - | 66 |
Date | Title | Funded by | Project Role* |
2015-2018 | Combining carbon monoxide-releasing molecules with anti-VEGF therapy for triple-negative breast cancer therapy | Life Sciences Research Network Wales, Cardiff University | PhD Researcher |
2013-2015 | Design, synthesis and biological evaluation of new anti-dyslipidemic morpholines with pleiotropic activity | - | MSc Researcher |
2012-2013 | Structurally improved antioxidant Trolox derivatives with pleiotropic activity | - | BSc Researcher |
Date | Title | Awarded by: |
2015 | Scholarship for PhD studies | Cardiff University's Schools of Medicine and Pharmacy & Pharmaceutical Sciences, and the Life Sciences Research Network Wales |
2010 | Rewarding Scholarship for Excellence | Department of Studies of the Aristotle University of Thessaloniki |
2009 | Scholarship for Excellence | Greek State Scholarship Foundation |